Heart pump therapy shows promise for long COVID sufferers

NCT ID NCT07492953

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a non-invasive treatment called enhanced external counterpulsation (EECP) can improve heart and lung function in adults with long COVID. Ten participants received EECP therapy on one of two schedules. Researchers measured exercise capacity, symptoms, and safety to see if the therapy helps recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-COVID-19 CONDITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19 post-COVID-19 disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Natioanl Denfense Medical University

    Taipei, 114, Taiwan